- Home
- MREO vs NWPX Comparison
MREO vs NWPX Comparison
Compare MREO & NWPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- NWPX
- Stock Information
- Founded
- MREO 2015
- NWPX 1966
- Country
- MREO United Kingdom
- NWPX United States
- Employees
- MREO N/A
- NWPX N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- NWPX Steel/Iron Ore
- Sector
- MREO Health Care
- NWPX Industrials
- Exchange
- MREO Nasdaq
- NWPX Nasdaq
- Market Cap
- MREO 438.8M
- NWPX N/A
- IPO Year
- MREO N/A
- NWPX 1995
- Fundamental
- Price
- MREO $2.89
- NWPX $42.78
- Analyst Decision
- MREO Strong Buy
- NWPX Hold
- Analyst Count
- MREO 5
- NWPX 1
- Target Price
- MREO $7.60
- NWPX $55.00
- AVG Volume (30 Days)
- MREO 1.2M
- NWPX 56.6K
- Earning Date
- MREO 08-12-2025
- NWPX 07-30-2025
- Dividend Yield
- MREO N/A
- NWPX N/A
- EPS Growth
- MREO N/A
- NWPX 37.25
- EPS
- MREO N/A
- NWPX 3.27
- Revenue
- MREO N/A
- NWPX $495,448,000.00
- Revenue This Year
- MREO N/A
- NWPX $1.41
- Revenue Next Year
- MREO $52.34
- NWPX $6.07
- P/E Ratio
- MREO N/A
- NWPX $13.09
- Revenue Growth
- MREO N/A
- NWPX 8.06
- 52 Week Low
- MREO $1.58
- NWPX $32.29
- 52 Week High
- MREO $5.02
- NWPX $57.76
- Technical
- Relative Strength Index (RSI)
- MREO 61.42
- NWPX 69.04
- Support Level
- MREO $2.63
- NWPX $38.38
- Resistance Level
- MREO $2.94
- NWPX $42.99
- Average True Range (ATR)
- MREO 0.15
- NWPX 1.14
- MACD
- MREO -0.00
- NWPX 0.40
- Stochastic Oscillator
- MREO 79.41
- NWPX 95.03
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).